Type 2 Diabetes Mellitus and Heart Failure: A Position Statement from the Heart Failure Association of the European Society of Cardiology
Petar Seferović, John J.V. McMurray(University of Glasgow), Frank Ruschitzka(Kantonsspital St. Gallen), Johann Bauersachs(Medizinische Hochschule Hannover), Walter J. Paulus(Ludwig-Maximilians-Universität München), Gerasimos Filippatos(National and Kapodistrian University of Athens), Henrik Wiggers(Aarhus University), Theresa A. McDonagh, Rudolf A. de Boer(Erasmus MC), Arno W. Hoes(University Medical Center Utrecht), Ivan Milinković(University of Belgrade), Jillian Riley(Lung Institute), Ekaterini Lambrinou, Jennifer Logue(University of Glasgow), Jelena P. Seferović(University of Belgrade), Mitja Lainščak, Mamas A. Mamas(University Hospitals of North Midlands NHS Trust), Dimitrios Farmakis(National and Kapodistrian University of Athens), Marija Polovina(University of Belgrade), Giuseppe Rosano(St George's Hospital), Dirk J. van Veldhuisen(University Medical Center Groningen), Francesco Cosentino(Linköping University), Michael J. Theodorakis(National and Kapodistrian University of Athens), Wolfram Doehner(Deutsches Herzzentrum der Charité), Alexandre Mebazaa(Marqueurs cardiovasculaires en situation de stress), Massimo Piepoli(University of Milan), Aldo P. Maggioni(Health Care Foundation), Carsten Tschöpe(Deutsches Herzzentrum der Charité), Stefan D. Anker(Charité - Universitätsmedizin Berlin), John Lekakis(British Heart Foundation), Yu. M. Lopatin(Volgograd State Medical University), Michel Komajda(Hôpital Saint Joseph), Mark C. Petrie(British Heart Foundation)
Cited by 716
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
|European Heart Journal|2012|6.9k
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
2016 European Guidelines on cardiovascular disease prevention in clinical practice
|European Heart Journal|2016|6.5k
Dapagliflozin in Patients with Chronic Kidney Disease
|New England Journal of Medicine|2020|5.2k